Benefit–risk assessment of esketamine nasal spray vs placebo in treatment‐resistant depression - MD Linx

Submitted by Anonymous (not verified) on Wed, 10/14/2020 - 14:24

Benefit–risk assessment of esketamine nasal spray vs placebo in treatment‐resistant depression  MD Linx